{"id":"placebo-to-match-peg-t-1","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL405705","moleculeType":"Small molecule","molecularWeight":"1256.27"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo formulations in clinical trials are inert preparations that mimic the active drug's physical properties, route of administration, and dosing schedule to maintain blinding and reduce bias. This specific placebo is engineered to match PEG-Tα1, a pegylated immunomodulatory peptide, allowing for proper control comparisons in phase 3 trials without conveying the active drug's therapeutic effects.","oneSentence":"This is a placebo control formulation designed to match the appearance and administration characteristics of PEG-Tα1 (pegylated thymosin alpha 1) for blinded clinical trial purposes.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:28:42.745Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT02366208","phase":"PHASE2","title":"Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B","status":"COMPLETED","sponsor":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","startDate":"2011-05","conditions":"Hepatitis B, Chronic","enrollment":116},{"nctId":"NCT02366247","phase":"PHASE3","title":"Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B","status":"UNKNOWN","sponsor":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","startDate":"2013-08","conditions":"Hepatitis B, Chronic","enrollment":463}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo to match PEG-Tα1","genericName":"Placebo to match PEG-Tα1","companyName":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","companyId":"jiangsu-hansoh-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}